Kathryn Parsley
Vice President Regulatory Affairs, Complement Therapeutics
Professional Overview
Kathryn Parsley is an experienced regulatory affairs professional with a strong track record of success in the pharmaceutical and biotechnology industries. As the Vice President of Regulatory Affairs at Complement Therapeutics, she leverages her deep expertise in regulatory strategy, compliance, and global market access to drive the successful development and commercialization of innovative therapies.
Experience Summary
Current Role
As the Vice President of Regulatory Affairs at Complement Therapeutics, Kathryn is responsible for leading the company's regulatory strategy and ensuring compliance with all applicable regulations across global markets. She works closely with cross-functional teams to navigate the complex regulatory landscape, secure timely approvals, and support the company's growth and expansion initiatives.
Career Progression
Kathryn has held progressive roles in regulatory affairs, steadily advancing her expertise and making significant contributions to the industry. Prior to joining Complement Therapeutics, she served as the Senior Global Program Regulatory Director at Novartis, where she played a pivotal role in the successful regulatory approval and launch of several critical drug products. Before that, she held various leadership positions at Gyroscope Therapeutics, including Acting VP and Head of Regulatory Affairs, where she spearheaded the company's regulatory strategy and successfully guided multiple product candidates through the clinical development and approval process.
Kathryn's earlier career experience includes roles at Boyds and PPD, where she gained extensive expertise in regulatory affairs, project management, and cross-functional collaboration. She also has a background in clinical research and immunology, having worked as a Clinical Scientist and GMP Manufacturing Production Manager at Great Ormond Street Hospital for Children NHS Foundation Trust.
Academic Background
Kathryn holds a Ph.D. in Immunology from the UCL GOS Institute of Child Health, where her research focused on advancing the understanding of pediatric immune disorders. She also has a strong foundation in medical technology, having previously worked as a Medical Technologist at the Centre for Applied Microbiology and Research (CAMR).
Areas of Expertise
- Regulatory strategy and compliance
- Global market access and product approvals
- Cross-functional collaboration and project management
- Immunology and clinical research
- GMP manufacturing and quality assurance
Professional Impact
Throughout her career, Kathryn has made significant contributions to the pharmaceutical and biotechnology industries. Her leadership and regulatory expertise have been instrumental in the successful development and commercialization of multiple innovative therapies, positively impacting the lives of patients and advancing the frontiers of medical science.
Conclusion
Kathryn Parsley is a highly respected regulatory affairs professional with a proven track record of success. In her current role as the Vice President of Regulatory Affairs at Complement Therapeutics, she continues to drive the company's growth and expansion by navigating the complex regulatory landscape, securing timely approvals, and ensuring compliance with global standards. With her deep expertise, cross-functional leadership, and commitment to advancing the industry, Kathryn is poised to make a lasting impact on the pharmaceutical and biotechnology sectors.
